PTP1B-IN-17 (Compound 45) 是一种有潜力的选择性苯并咪唑衍生物，可作为蛋白质酪氨酸磷酸酶 1B (PTP1B) 抑制剂，Ki为 30.2 μM。PTP1B-IN-17 可用于 2 型糖尿病的研究。

PTP1B-IN-17 (Compound 45), a potential selective benzimidazole derivative, acts as a protein tyrosine phosphatase 1B ( PTP1B ) inhibitor with a K i of 30.2 μM. PTP1B-IN-17 can be used for the research of type 2 diabetes.

C26H19N3O4S

469.51

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years